Pancreatic neuroendocrine tumors (PNETs) are known to be the second most common
epithelial malignancy of the pancreas. PNETs can be listed among the slowest growing as …

Pancreatic neuroendocrine tumors (PNETs) are a heterogeneous and orphan group of
neoplasms that vary in their histology, clinical features, prognosis, and management. The …

Pancreatic neuroendocrine tumours (PanNETs) are considered a relatively unusual
oncologic entity. Due to its relative good prognosis, surgery remains the goal standard …

Neuroendocrine tumors (NETs) describe a heterogeneous group of tumors with a wide
range of morphologic, functional, and behavioral characteristics. These tumors are generally …

The incidence of pancreatic neuroendocrine tumors (PNETs) has significantly increased in
recent years, although this may reflect better detection and improved diagnosis, in addition …

Pancreatic neuroendocrine neoplasms (pNENs) are a heterogeneous group of tumors
including well differentiated pancreatic neuroendocrine tumors (pNETs) and …

Pancreatic neuroendocrine tumors (PNETs) are the second most common primary
pancreatic neoplasms after pancreatic ductal adenocarcinoma. PNETs present with widely …

Pancreatic neuroendocrine tumours (pNETs) are a rare form of pancreatic cancer. Several
therapeutic options exist for pNETS; however, there is no algorithm to determine the …

Pancreatic neuroendocrine tumors (NETs) are a heterogeneous group of tumors. Despite
being relatively rare, representing just 1–2% of all pancreatic neoplasms, the incidence of …

Pancreatic neuroendocrine tumors (pNETs) differ in their clinical behavior, presentation and
prognosis based on their initial histological features and disease stage. While small …